Myocarditis Following SARS-CoV2 mRNA Vaccination Against COVID-19: Facts and Open Questions.

dc.contributor.author	Heymans, Stephane
dc.contributor.author	Dawson, Dana
dc.contributor.author	Fuster, Valentin
dc.contributor.author	Metra, Marco
dc.contributor.author	Tocchetti, Carlo Gabriele
dc.date.accessioned	2023-11-06T13:32:58Z
dc.date.available	2023-11-06T13:32:58Z
dc.date.issued	2022-10-04
dc.identifier.citation	J Am Coll Cardiol. 2022 Oct 4;80(14):1363-1365.	es_ES
dc.identifier.uri	http://hdl.handle.net/20.500.12105/16646
dc.language.iso	eng	es_ES
dc.publisher	Elsevier	es_ES
dc.type.hasVersion	VoR	es_ES
dc.rights.uri	http://creativecommons.org/licenses/by-nc-nd/4.0/	*
dc.subject.mesh	COVID-19	es_ES
dc.subject.mesh	Myocarditis	es_ES
dc.subject.mesh	Humans	es_ES
dc.subject.mesh	RNA, Messenger	es_ES
dc.subject.mesh	RNA, Viral	es_ES
dc.subject.mesh	SARS-CoV-2	es_ES
dc.subject.mesh	Vaccination	es_ES
dc.title	Myocarditis Following SARS-CoV2 mRNA Vaccination Against COVID-19: Facts and Open Questions.	es_ES
dc.type	journal article	es_ES
dc.rights.license	Attribution-NonCommercial-NoDerivatives 4.0 Internacional	*
dc.identifier.pubmedID	36175054	es_ES
dc.format.volume	80	es_ES
dc.format.number	14	es_ES
dc.format.page	1363	es_ES
dc.identifier.doi	10.1016/j.jacc.2022.08.003	es_ES
dc.description.peerreviewed	Sí	es_ES
dc.identifier.e-issn	1558-3597	es_ES
dc.relation.publisherversion	10.1016/j.jacc.2022.08.003	es_ES
dc.identifier.journal	Journal of the American College of Cardiology	es_ES
dc.repisalud.orgCNIC	CNIC::Grupos de investigación::Imagen Cardiovascular y Estudios Poblacionales	es_ES
dc.repisalud.institucion	CNIC	es_ES
dc.rights.accessRights	open access	es_ES